Erik M Volz
Title
Cited by
Cited by
Year
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
N Ferguson, D Laydon, G Nedjati Gilani, N Imai, K Ainslie, M Baguelin, ...
25672020
Estimates of the severity of coronavirus disease 2019: a model-based analysis
R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ...
The Lancet infectious diseases 20 (6), 669-677, 2020
23282020
Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in European countries: technical description update
S Flaxman, S Mishra, A Gandy, HJT Unwin, H Coupland, TA Mellan, ...
arXiv preprint arXiv:2004.11342, 2020
6172020
Probability based estimation theory for respondent driven sampling
E Volz, DD Heckathorn
Journal of official statistics 24 (1), 79, 2008
5842008
SIR dynamics in random networks with heterogeneous connectivity
E Volz
Journal of mathematical biology 56 (3), 293-310, 2008
3352008
Susceptible–infected–recovered epidemics in dynamic contact networks
E Volz, LA Meyers
Proceedings of the Royal Society B: Biological Sciences 274 (1628), 2925-2934, 2007
3012007
Viral phylodynamics
EM Volz, K Koelle, T Bedford
PLoS Comput Biol 9 (3), e1002947, 2013
2882013
Edge-based compartmental modelling for infectious disease spread
JC Miller, AC Slim, EM Volz
Journal of the Royal Society Interface 9 (70), 890-906, 2012
2182012
Epidemic thresholds in dynamic contact networks
E Volz, LA Meyers
Journal of the Royal Society Interface 6 (32), 233-241, 2009
2092009
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
2022021
Phylodynamics of infectious disease epidemics
EM Volz, SL Kosakovsky Pond, MJ Ward, AJ Leigh Brown, SDW Frost
Genetics 183 (4), 1421-1430, 2009
1982009
Phylodynamics of infectious disease epidemics
EM Volz, SL Kosakovsky Pond, MJ Ward, AJ Leigh Brown, SDW Frost
Genetics 183 (4), 1421-1430, 2009
1982009
Respondent-driven sampling analysis tool (RDSAT) version 7.1
E Volz, C Wejnert, C Cameron, M Spiller, V Barash, I Degani, ...
Ithaca, NY: Cornell University, 2012
1942012
Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations
A Rambaut, N Loman, O Pybus, W Barclay, J Barrett, A Carabelli, ...
Genom. Epidemiol, 2020
1882020
Effects of heterogeneous and clustered contact patterns on infectious disease dynamics
EM Volz, JC Miller, A Galvani, LA Meyers
PLoS Comput Biol 7 (6), e1002042, 2011
1792011
Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
medRxiv, 2020.12. 30.20249034, 2021
1772021
Estimates of the severity of COVID-19 disease
R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ...
MedRxiv, 2020
1742020
A discrete-choice approach to modeling social influence on individual decision making
A Pez, DM Scott, E Volz
Environment and Planning B: Planning and Design 35 (6), 1055-1069, 2008
1522008
Disease transmission in territorial populations: the small-world network of Serengeti lions
ME Craft, E Volz, C Packer, LA Meyers
Journal of the Royal Society Interface 8 (59), 776-786, 2011
1472011
Innovative recruitment using online networks: lessons learned from an online study of alcohol and other drug use utilizing a web-based, respondent-driven sampling (webRDS) strategy
JA Bauermeister, MA Zimmerman, MM Johns, P Glowacki, S Stoddard, ...
Journal of Studies on Alcohol and Drugs 73 (5), 834-838, 2012
1462012
The system can't perform the operation now. Try again later.
Articles 1–20